The booming real estate markets in the National Capital Region, Mumbai and Bangalore registered the highest global yields in 2003, according to the latest updates by Chesterton Meghraj, a global real estate consulting group.
The markets opened firm on Tuesday and crossed the 7,800 mark after opening with a gain of 7 points at 7,774.
The markets opened strong on F&O expiry today despite some mixed global cues
The NSE 50-share after moving between 10,309.85 and 10,261.50 on alternate bouts of selling and buying, finished at 10,298.75, with paltry gains of 15.15 points, or 0.15 per cent.
'We cannot have bodies putrefying in water.' 'This is a health hazard and it can create a very inflammatory situation.'
The chief minister had sanctioned Rs 50,000 to the girl for undergoing plastic surgery and reconstruction of her disfigured face.
The Nifty gained 47 points to close at 3,605.\n\n
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
The Sensex slipped into negative territory, after opening 14 points up at 7,765.
Some Indian generic drugmakers are, however, uncertain about the pace of approvals in the near future.
The index touched a low of 14,026, before settling with a loss of 168 points at 14,041.
Asia's falling stocks have triggered an exodus of funds from the region.
An insider said that over the past decade or so Cipla has become immune to the exits of leaders. There have been no directional change in the long-term strategies.
US markets have been very lucrative for the Indian pharma companies and many companies such as Ranbaxy and Dr Reddy's capitalised on this opportunity.
The markets opened in the positive terrain after seeing a flat close yesterday
The Sensex opened past the 8,200-mark at 8,208 as against Wednesday's close of 8,189 and later rallied smartly to a high of 8,252.
The markets opened flat on the back of weak Asian and US cues
With rains once again lashing Mumbai, the Sensex opened weak and is now down 20 points at 7616. Nifty is down 8 points at 2304.
A key lesson for the pharmaceutical sector in this case is to not downplay the significant impact that regulatory non-compliance can have on operations.
Domestic pharma giant Ranbaxy Laboratories Limited has topped the list of patent filers in the area of drug applications from the Third World countries last year with 64 new formulations.\n\n\n\n
